Study of Pembrolizumab With Bendamustine in Hodgkin Lymphoma
Clinical trial NCT04510636 · RECRUITING
Trial details
- NCT number
- NCT04510636
- Sponsor
- University Health Network, Toronto
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-20
- Primary completion
- 2026-11-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.